Trial Profile
Multi-center Clinical Trial of the Application of Ixmyelocel-T in the Treatment of Osteonecrosis of the Femoral Head
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Autologous cultured chondrocytes (Primary)
- Indications Osteonecrosis
- Focus Therapeutic Use
- Acronyms ON-CORE
- Sponsors Vericel Corporation
- 27 Jun 2014 New trial record